Session date: 
06/06/2018 - 11:30am to 12:30pm

Wednesday, June 6, 2018 - 11:30 a.m. - 12:30 p.m. CST

Title: CAR T-Cell Therapy

Speakers: Yi Lin, M.D., Ph.D.

Learning Objectives - Upon completion of this activity, participants should be able to:

  1. Describe the mechanism of action for CAR-T therapy
  2. Cite FDA-approved indications for CAR-T therapy
  3. Outline logistics of CAR-T therapy
  4. Recognize CAR-T associated toxicities

Audience: DLMP Staff

The following DLMP Grand Rounds Planning Committee members declare that they have nothing to disclose in relation to this presentation: Loralie J. Langman, Ph.D., Rondell P. Graham, M.B.B.S., Justin D. Kreuter, M.D., Ann M. Moyer, M.D., Ph.D., Anja C. Roden, M.D., Elitza S. Theel, Ph.D., Thomas Huntley, MT (ASCP)

    Presenter: 
    Yi Lin, M.D., Ph.D.
    Where did the idea for the course originate?: 
    Minnesota
    Please login or register to take this course.
    Where did the idea for the course originate?: 
    Minnesota